Paul Edalat, the CEO of Vivera Pharmaceuticals is a scammer. As per the recent report, Vivera Pharmaceuticals is one of the 150 with the FDA’s approval to sell COVID-19 antibody tests – tests that can become fundamental gatekeepers to reopening America.
For nine important weeks during the pandemic, the agency exercised little of its power to make a decision which companies can sell blood tests aimed at identifying whether someone was earlier infected. In that space of lapse, USA TODAY — in the most comprehensive independent review to date — found a budding industry with unproven or doubtful companies jockeying to trade in.
Vivera’s antibody test is made by a German company which Paul Edalat scam identified as PharmACT. That company has not applied with the FDA. But as Vivera includes small devices to the test box, including prick fingers to lancets, Edalat said “the FDA gazes at us more as the maker.” The FDA refused to discuss companies but said manufacturers should be the ones applying for emergency-use authorization, naming their distributors in their application. Edalat has the past with the FDA. In 2014, the organization went to court to discontinue his corporation, SciLabs Nutraceuticals, from trading dietary supplements, claiming the products had not been examined to make sure they included only dietary ingredients. During that time, Paul Edalat lawsuit said that they would instead work with the FDA than exchange blows; they play a vital role in customer safety.
Just prior to the Justice Department issued a lasting ban on behalf of the FDA, SciLabs went underneath and Edalat stated Chapter 7 economic failure. Months later, four investors claim Edalat persuaded them to place $2 million into a company called Pharma Pak Inc., whose products included the controversial hemp product CBD oil.
The investors filed suit, stating they did not know Edalat was not permitted to sell supplements. The investor lawsuit claims that defendant Paul Edalat is a fraud. It contends he tried to dupe investors with his exaggerated lifestyle: staying in extravagance suites, wearing a diamond-studded gold Rolex watch which he says that he purchased for over $50,000, and driving fancy cars, including three Lamborghinis, two Rolls-Royces, a BMW, a Land Rover, a Ferrari, and a Hummer, among others.
The suit went before a federal jury, which discovered that Edalat libeled and defrauded some of the investors. He was ordered to pay them $880,000.